المؤلفون: Shapiro MA; University of Florida College of Medicine Department of Psychiatry; Children's Hospital of the King's Daughters, Eastern Virginia Medical School., John SA; University of Florida College of Medicine Department of Psychiatry., Muzwagi AB; University of Florida College of Medicine Department of Psychiatry., Silverman AL; University of Florida College of Medicine Department of Psychiatry., Soda T; University of Florida College of Medicine Department of Psychiatry.

المصدر: Psychodynamic psychiatry [Psychodyn Psychiatry] 2024 Jun; Vol. 52 (2), pp. 189-205.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Guilford Press Country of Publication: United States NLM ID: 101580621 Publication Model: Print Cited Medium: Internet ISSN: 2162-2604 (Electronic) Linking ISSN: 21622590 NLM ISO Abbreviation: Psychodyn Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Child Abuse*/legislation & jurisprudence , Child Abuse*/ethics , Countertransference* , Mandatory Reporting*/ethics, Humans ; United States ; Infant, Newborn ; Child ; Female

المؤلفون: Oka Y; Department of Personalized Medicine and Preventive Healthcare Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Matsumoto J; Department of Personalized Medicine and Preventive Healthcare Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. matsumotoj@okayama-u.ac.jp.; Department of Education and Research Centre for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. matsumotoj@okayama-u.ac.jp.; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. matsumotoj@okayama-u.ac.jp., Takeda T; Department of Education and Research Centre for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Iwata N; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Niimura T; Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, 2-50-1 Kuramoto-cho, Tokushima, 700-8503, Japan., Ozaki AF; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California Irvine, 101 Theory Ste 100, Irvine, CA, 92697, USA., Bekku K; Department of Urology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Hamano H; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Araki M; Department of Urology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Ishizawa K; Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, 2-50-1 Kuramoto-cho, Tokushima, 700-8503, Japan., Zamami Y; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Ariyoshi N; Department of Personalized Medicine and Preventive Healthcare Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.; Department of Education and Research Centre for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

المصدر: International journal of clinical pharmacy [Int J Clin Pharm] 2024 Jun; Vol. 46 (3), pp. 745-750. Date of Electronic Publication: 2024 Apr 17.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-7711 (Electronic) NLM ISO Abbreviation: Int J Clin Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Ipilimumab*/adverse effects , Ipilimumab*/administration & dosage , Pharmacovigilance* , Nivolumab*/adverse effects , Nivolumab*/administration & dosage , Carcinoma, Renal Cell*/drug therapy , Pyridines*/adverse effects , Pyridines*/administration & dosage , Kidney Neoplasms*/drug therapy , Anilides*/adverse effects , Anilides*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Adverse Drug Reaction Reporting Systems*/statistics & numerical data, Humans ; Male ; Female ; Middle Aged ; Aged ; Databases, Factual ; Adult ; United States/epidemiology

المؤلفون: Park T; Pharmacy Administration and Public Health, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA., Hwang M; Pharmacy Administration and Public Health, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA.

المصدر: Expert review of cardiovascular therapy [Expert Rev Cardiovasc Ther] 2024 Jun; Vol. 22 (6), pp. 273-283. Date of Electronic Publication: 2024 May 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101182328 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8344 (Electronic) Linking ISSN: 14779072 NLM ISO Abbreviation: Expert Rev Cardiovasc Ther Subsets: MEDLINE

مواضيع طبية MeSH: Pharmacovigilance* , Cardiovascular Diseases*/chemically induced , Cardiovascular Diseases*/epidemiology , Adverse Drug Reaction Reporting Systems*/statistics & numerical data , Cardiovascular Agents*/adverse effects, Humans ; United States ; Databases, Factual ; Drug Approval ; United States Food and Drug Administration ; Male ; Product Surveillance, Postmarketing ; Female ; Middle Aged ; Drug Combinations

المؤلفون: Wang Q; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China., Qu K; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China., Du Z; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China., Shen Y; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China., Jiang Y; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China., Zhu H; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China.

المصدر: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2024 Jun; Vol. 38 (6), pp. 562-566. Date of Electronic Publication: 2024 Apr 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Tetrabenazine*/analogs & derivatives , Tetrabenazine*/adverse effects , United States Food and Drug Administration* , Adverse Drug Reaction Reporting Systems*/statistics & numerical data , Valine*/analogs & derivatives , Valine*/adverse effects, Humans ; United States ; Databases, Factual ; Data Mining/methods ; Tardive Dyskinesia/chemically induced ; Male ; Bayes Theorem ; Adult

المؤلفون: Almutairi KB; School of Medicine, The University of Western Australia, Perth, Australia. khalid.almutairi@uwa.edu.au.; King Fahd Specialist Hospital, Burydah, Saudi Arabia. khalid.almutairi@uwa.edu.au., Inderjeeth CA; School of Medicine, The University of Western Australia, Perth, Australia.; Sir Charles Gairdner and Osborne Park Health Care Group, Perth, Australia., Preen DB; School of Population and Global Health, University of Western Australia, Perth, WA, Australia., Keen HI; School of Medicine, The University of Western Australia, Perth, Australia.; Fiona Stanley Hospital, Murdoch, WA, Australia., Nossent JC; School of Medicine, The University of Western Australia, Perth, Australia.; Sir Charles Gairdner and Osborne Park Health Care Group, Perth, Australia.

المصدر: Rheumatology international [Rheumatol Int] 2024 Jun; Vol. 44 (6), pp. 1089-1099. Date of Electronic Publication: 2024 Apr 14.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-160X (Electronic) Linking ISSN: 01728172 NLM ISO Abbreviation: Rheumatol Int Subsets: MEDLINE

مواضيع طبية MeSH: Antirheumatic Agents*/adverse effects , Pharmacovigilance* , Adverse Drug Reaction Reporting Systems*/statistics & numerical data, Humans ; Female ; Western Australia/epidemiology ; Middle Aged ; Retrospective Studies ; Aged ; Male ; Adult ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Databases, Factual ; United States/epidemiology ; Time Factors ; Young Adult

المؤلفون: Cervantes-Arellano MJ; Anatomy Department, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico., Castelán-Martínez OD; Clinical Pharmacology Laboratory, UMIEZ, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México (UNAM), Batalla 5 de Mayo s/n Esquina Fuerte de Loreto, Col. Ejército de Oriente, Iztapalapa, Mexico City, C.P. 09230, Mexico. castelan@unam.mx., Marín-Campos Y; Pharmacology Department, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico., Chávez-Pacheco JL; Clinical Pharmacology Laboratory, Instituto Nacional de Pediatría, Mexico City, Mexico., Morales-Ríos O; Unidad Habilitada de Apoyo al Predictamen, Hospital Infantil de México Federico Gómez, Mexico City, Mexico., Ubaldo-Reyes LM; Anatomy Department, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.

المصدر: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences [Daru] 2024 Jun; Vol. 32 (1), pp. 421-434. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis; Review

بيانات الدورية: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101125969 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2008-2231 (Electronic) Linking ISSN: 15608115 NLM ISO Abbreviation: Daru Subsets: MEDLINE

مواضيع طبية MeSH: Pharmacovigilance* , Health Knowledge, Attitudes, Practice* , Health Personnel*/education , Adverse Drug Reaction Reporting Systems* , Drug-Related Side Effects and Adverse Reactions*/prevention & control, Humans

المؤلفون: Fusaroli M; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. michele.fusaroli2@unibo.it., Salvo F; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France. francesco.salvo@u-bordeaux.fr.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France. francesco.salvo@u-bordeaux.fr., Begaud B; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France., AlShammari TM; College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia., Bate A; Global Safety, GSK, Brentford, UK.; Department of Non-Communicable Epidemiology, London School of Hygiene and Tropical Medicine, London, UK., Battini V; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy., Brueckner A; Novartis Pharma AG, Basel, Switzerland., Candore G; Medical Affairs and Pharmacovigilance, Bayer AG, Berlin, Germany., Carnovale C; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy., Crisafulli S; Department of Medicine, University of Verona, Verona, Italy., Cutroneo PM; Unit of Clinical Pharmacology, Sicily Pharmacovigilance Regional Centre, University Hospital of Messina, Messina, Italy., Dolladille C; UNICAEN, EA4650 SEILIRM, CHU de Caen Normandie, Normandie University, Caen, France.; Department of Pharmacology, CHU de Caen Normandie, Caen, France., Drici MD; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center, Nice, France., Faillie JL; Desbrest Institute of Epidemiology and Public Health, Department of Medical Pharmacology and Toxicology, INSERM, Univ Montpellier, Regional Pharmacovigilance Centre, CHU Montpellier, Montpellier, France., Goldman A; Department of Internal Medicine, Sheba Medical Center, Ramat-Gan, Israel.; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Hauben M; Pfizer Inc, New York, NY, USA.; Department of Family and Community Medicine, New York Medical College, Valhalla, New York, USA., Herdeiro MT; Department of Medical Sciences, IBIMED-Institute of Biomedicine, University of Aveiro, 3810-193, Aveiro, Portugal., Mahaux O; Global Safety, GSK, Brentford, UK., Manlik K; Medical Affairs and Pharmacovigilance, Bayer AG, Berlin, Germany., Montastruc F; Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), Toulouse, France.; CIC 1436, Team PEPSS (Pharmacologie En Population cohorteS et biobanqueS), Toulouse University Hospital, Toulouse, France., Noguchi Y; Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan., Norén GN; Uppsala Monitoring Centre, Uppsala, Sweden., Noseda R; Institute of Pharmacological Sciences of Southern Switzerland, Division of Clinical Pharmacology and Toxicology, Ente Ospedaliero Cantonale, Lugano, Switzerland., Onakpoya IJ; Department for Continuing Education, University of Oxford, Oxford, UK., Pariente A; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France., Poluzzi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Salem M; Health Canada, Ottawa, ON, Canada., Sartori D; Uppsala Monitoring Centre, Uppsala, Sweden.; Centre for Evidence-Based Medicine, Nuffield, Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Trinh NTH; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway., Tuccori M; Tuscany Regional Centre, Unit of Adverse Drug Reaction Monitoring, University Hospital of Pisa, Pisa, Italy., van Hunsel F; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.; PharmacoTherapy, Epidemiology and Economics, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands., van Puijenbroek E; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.; PharmacoTherapy, Epidemiology and Economics, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands., Raschi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Khouri C; Pharmacovigilance Department, Université Grenoble Alpes, Grenoble Alpes University Hospital, Grenoble, France.; UMR 1300-HP2 Laboratory, Université Grenoble Alpes, INSERM, Grenoble Alpes University, Grenoble, France.

المصدر: Drug safety [Drug Saf] 2024 Jun; Vol. 47 (6), pp. 585-599. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Pharmacovigilance* , Adverse Drug Reaction Reporting Systems*/statistics & numerical data , Adverse Drug Reaction Reporting Systems*/standards , Drug-Related Side Effects and Adverse Reactions*/epidemiology, Humans ; Guidelines as Topic

المؤلفون: Fusaroli M; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Salvo F; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France., Begaud B; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France., AlShammari TM; College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia., Bate A; Global Safety, GSK, Brentford, UK.; Department of Non-Communicable Epidemiology, London School of Hygiene and Tropical Medicine, London, UK., Battini V; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy., Brueckner A; Novartis, Basel, Switzerland., Candore G; Bayer AG, Medical Affairs and Pharmacovigilance, Berlin, Germany., Carnovale C; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy., Crisafulli S; Department of Medicine, University of Verona, Verona, Italy., Cutroneo PM; Unit of Clinical Pharmacology, Sicily Pharmacovigilance Regional Centre, University Hospital of Messina, Messina, Italy., Dolladille C; UNICAEN, EA4650 SEILIRM, CHU de Caen Normandie, Normandie University, Caen, France.; Department of Pharmacology, CHU de Caen Normandie, Caen, France., Drici MD; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center, Nice, France., Faillie JL; Desbrest Institute of Epidemiology and Public Health, Department of Medical Pharmacology and Toxicology, INSERM, Univ Montpellier, Regional Pharmacovigilance Centre, CHU Montpellier, Montpellier, France., Goldman A; Department of Internal Medicine, Sheba Medical Center, Ramat-Gan, Israel.; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Hauben M; Pfizer Inc., New York, USA.; Department of Family and Community Medicine, New York Medical College, Valhalla, New York, USA., Herdeiro MT; Department of Medical Sciences, IBIMED-Institute of Biomedicine, University of Aveiro, 3810-193, Aveiro, Portugal., Mahaux O; Global Safety, GSK, Brentford, UK., Manlik K; Bayer AG, Medical Affairs and Pharmacovigilance, Berlin, Germany., Montastruc F; Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), Toulouse, France.; CIC 1436, Team PEPSS (Pharmacologie En Population cohorteS et biobanqueS), Toulouse University Hospital, Toulouse, France., Noguchi Y; Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan., Norén GN; Uppsala Monitoring Centre, Uppsala, Sweden., Noseda R; Institute of Pharmacological Sciences of Southern Switzerland, Division of Clinical Pharmacology and Toxicology, Ente Ospedaliero Cantonale, Lugano, Switzerland., Onakpoya IJ; Department for Continuing Education, University of Oxford, Oxford, UK., Pariente A; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France., Poluzzi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Salem M; Health Canada, Ottawa, Canada., Sartori D; Uppsala Monitoring Centre, Uppsala, Sweden.; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Trinh NTH; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway., Tuccori M; Tuscany Regional Centre, Unit of Adverse Drug Reaction Monitoring, University Hospital of Pisa, Pisa, Italy., van Hunsel F; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands.; University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology and Economics, Groningen, the Netherlands., van Puijenbroek E; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands.; University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology and Economics, Groningen, the Netherlands., Raschi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. emanuel.raschi@unibo.it., Khouri C; Pharmacovigilance Department, Univ. Grenoble Alpes, Grenoble Alpes University Hospital, Grenoble, France. ckhouri@chu-grenoble.fr.; UMR 1300-HP2 Laboratory, Univ. Grenoble Alpes, INSERM, Grenoble Alpes University, Grenoble, France. ckhouri@chu-grenoble.fr.

المصدر: Drug safety [Drug Saf] 2024 Jun; Vol. 47 (6), pp. 575-584. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Pharmacovigilance* , Adverse Drug Reaction Reporting Systems*/standards , Adverse Drug Reaction Reporting Systems*/statistics & numerical data , Drug-Related Side Effects and Adverse Reactions*/epidemiology, Humans ; Delphi Technique ; Checklist ; Consensus ; Guidelines as Topic

المؤلفون: Cocco M; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.; Department of Drug Sciences, University of Pavia, Pavia, Italy., Carnovale C; Pharmacovigilance & Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università Degli Studi di Milano, Milan, Italy., Clementi E; Pharmacovigilance & Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università Degli Studi di Milano, Milan, Italy.; Scientific Institute, IRCCS E. Medea, Bosisio Parini, LC, Italy., Barbieri MA; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy., Battini V; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Sessa M; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.

المصدر: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2024 May-Jun; Vol. 17 (5-6), pp. 441-453. Date of Electronic Publication: 2024 Apr 18.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278296 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-2441 (Electronic) Linking ISSN: 17512433 NLM ISO Abbreviation: Expert Rev Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Drug Interactions* , Adverse Drug Reaction Reporting Systems* , Databases, Factual* , Drug-Related Side Effects and Adverse Reactions*/prevention & control, Humans ; Time Factors

المؤلفون: Ren X; Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: erxia100@163.com., Wang H; Department of Intensive Care Unit, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: haijun99@126.com., Deng L; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: dengleipumc@163.com., Wang W; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: wwq4350524@163.com., Wang Y; Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic address: wangyf@cicams.ac.cn.

المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Jul 30; Vol. 136, pp. 112301. Date of Electronic Publication: 2024 Jun 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Immune Checkpoint Inhibitors*/adverse effects , Pharmacovigilance* , Adverse Drug Reaction Reporting Systems*/statistics & numerical data , United States Food and Drug Administration* , Angiogenesis Inhibitors*/adverse effects , Angiogenesis Inhibitors*/therapeutic use , Databases, Factual*, Humans ; United States/epidemiology ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Neoplasms/drug therapy ; Adult ; Young Adult ; Adolescent ; Aged, 80 and over